2025 BioSymposium sponsors: Innovations in Technologies – Implantables, Neurotech, and Diagnostics
State Government of Victoria
Web djsir.vic.gov.au/health-tech
Email medtech.pharma@ecodev.vic.gov.au
About us
Victoria is home to world-class health technology companies and is a preferred location for many global leaders including CSL, Moderna, BioNTech, Illumina, Telix Pharmaceuticals and Pfizer. International companies partner with Victoria for its outstanding strengths in commercial product development, its cost-competitive environment for basic discovery, clinical and commercial research, and its strong collaborative networks and supportive government.
Victoria is a global leader in health technologies research and manufacturing, delivering a sector value add of $5.5 billion in 2022. Victoria’s research and development capabilities include: infectious disease and diagnostics; digital health and patient monitoring; cancer; cell therapies and regenerative medicine; neuroscience; paediatrics.
Victoria’s health technologies ecosystem is supported by its skilled and multicultural talent pool, favourable regulatory and research and development environment, and world leading infrastructure - all backed by the Victorian Government’s long-term investment into the sector.
The Victorian Government has recognised health technologies as a priority industry sector for more than two decades and is committed to working with business to grow the research and innovation ecosystem. The Victorian Government has a global network of 23 international business offices, actively working with companies worldwide to assist them to partner with Victoria to develop novel health technologies and services.
We look forward to connecting with you.
For more information on how the Victorian Government can support your business, please visit our website.
Blackhawk Alert
Email marc@blackhawkalert.com
About us
At Blackhawk Alert, we specialize in delivering data compliance & cyber security as a service. Our approach is comprehensive, addressing the full spectrum of data compliance needs across people, processes, and technology. From policies and procedures to technical controls and accreditation. We deliver geo-specific requirements and industry mandates.
At Blackhawk Alert, we empower medtech innovators with compliance-as-a-service solutions tailored to the unique challenges of bioelectronic medicine, neurostimulation, implantable devices, and diagnostics. Our expertise ensures that emerging technologies meet global regulatory standards, data security mandates, and patient safety requirements, accelerating the path from research to real-world application.
With coverage across 80+ business lines and 20+ regulatory frameworks, including TGA, FDA, MDR, HIPAA, and ISO standards, we help organizations navigate complex compliance landscapes, safeguarding patient data, clinical integrity, and market readiness.
PureCDM Pty Ltd
Contacts Helen Poliviou and Louise Christian
Email helen@purecdm.com.au louise.christian@purecdm.com.au
About us
PureCDM is an Australian-owned private company focused on the the management of clinical data for Biotech and Medtech companies globally. With over 25 years of cross-functional expertise, we specialise in customising technologies and positioning clinical data front and centre as each company’s most valuable asset.
We are committed to meeting the evolving needs and complexities of Biotechnology clinical trials, from SAD/MAD studies though to highly complex neurological, immuno-oncology and rare paediatric clinical trials, and have delivered data to support regulatory approvals by the EMEA, FDA and TGA.
Focusing on data collection pathways from clinic to analysis, our databases are custom designed to facilitate high quality data at the point of entry. We excel in designing within various industry-leading EDC systems and understand key pressure points within clinical trials, enabling us to optimise support to sites and clinical teams when meeting data deliverables.
Our scientific advisory team includes a quantitative clinical pharmacologist with 15+ years’ experience in drug development and life cycle management for small and large molecules in oncology, and a team of biostatisticians averaging 20+ years’ experience. All members have held roles in global pharma companies, supporting project strategy and regulatory submissions and leading to the worldwide approvals of targeted agents, including several that reached blockbuster status.
Graeme Clark Institute for Biomedical Engineering
Web http://clarkinstitute.unimelb.edu.au/
Email nguyen.m@unimelb.edu.au
About us
The Graeme Clark Institute for Biomedical Engineering was created with Strategic STEM-M Funds to coordinate biomedical engineering activities across the University of Melbourne’s Faculty of Engineering and Information Technology (FEIT), Faculty of Medicine, Dentistry and Health Sciences (MDHS), and Faculty of Science (FoS).
The vision for the GCI is to transform healthcare with biomedical engineering solutions that deliver global health, societal and economic benefits.
The GCI brings together expertise and capabilities from medicine, engineering, and science, including the life sciences, computer sciences, mathematics, and the social sciences to focus on:
- biomedical engineering research and its translation into practice to enhance the health outcomes of people; and
- the translation of learnings from fundamental science and human body systems into engineered systems.
SeerPharma Pty Ltd
Contact Biju Kishor
Email biju.kishor@seerpharma.com.au
About us
SeerPharma is a team of consultants that provide advice, training, software solutions from MasterControl, and contract labour resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region, on matters of Quality Assurance and GMP compliance. We have been serving our clients in the Asia-Pacific region for over 30 years from our offices in Australia and Singapore, and are also able to provide assistance in Europe through our affiliate in the UK.
Our team of consultants have extensive experience working with clients supplying or looking to enter the supply chain of a therapeutic product. We work with organisations looking to ensure that their facilities, equipment, quality systems and processes are compliant with FDA, PIC/S, TGA, WHO, ISO, ICH and other GxP regulations and standards that apply to their product(s).
Through our work we aim to “Advance Quality and GMP Best Practices in the APAC region” for the Pharmaceutical and Medical Device Industry.
FB Rice
Web https://www.fbrice.com.au/
Phone: +61 3 8618 4100
Email: contact@fbrice.com.au
About us
Founded over 70 years ago, FB Rice has become Australia's most trusted intellectual property firm, with offices nationwide and a well-established presence in New Zealand and South-East Asia.
Today, we bring world-leading expertise across biotechnology, chemistry, computer and electrical sciences, engineering, and medical devices. With a focus on integrity and determination, we are committed to helping our clients achieve their goals. Our distinct advantage lies in our independent status—without external obligations, our sole focus is on the success of our clients. This dedication is reflected in our accolades, including 15 Australian Client Choice Awards and seven consecutive titles as Best Specialist IP Firm.
With decades of experience, we understand that the right advice can be the difference between success and frustration. Our diverse, multidisciplinary team consistently goes the extra mile to leverage IP for maximum commercial impact.
At FB Rice, we nurture and grow best-in-class attorneys who excel not only in intellectual property but also in understanding our clients' environments. We tailor IP advice and strategy to each client's unique needs, always striving to provide exceptional service. Our expertise, coupled with a commitment to making our clients feel comfortable and respected at every stage, sets us apart. We build partnerships based on trust by being open, approachable, and completely focused on our clients’ needs.
At FB Rice, we champion innovation and create value.
Outerspace Design
Web: http://www.outerspace.co/
Contact: Fred Blochlinger
Email: fblochlinger@outerspace.co
About Us:
Established in 1990 in Richmond, Victoria. Outerspace Design has helped some of Australia’s best OEM companies develop world-renowned consumer and industrial products for domestic and international markets. Example of our medical clients include: Compumedics, Metron, Medmont, & Cochlear.
We design medical products that are user-focused and forward-thinking. We design with your customers in mind and we thrive on making products that they love. With our 30 strong team of designers and engineers we leverage that in house knowledge on every product we develop, whether it’s award winning structural packaging designs or patient monitoring devices.
Outerspace specialises in the following areas:
Medical Devices
Electronics
Leisure and Lifestyle Products
Consumer Products
Commercialisation of New Technologies
FMCG Structural Packaging
Services include
Product Development
Medical device design
Design for Manufacture
Mechanical Engineering
Industrial Design
Prototyping
Risk management
ISO 13485 ready process
Design History File
Concept to Market"
Electronic engineering
Firmware engineering
System architecture & IoT
Software development
Data handling
Oxford PharmaGenesis Pty Ltd
Web: http://www.pharmagenesis.com
Contact: Steven Inglis
Email: steven.inglis@pharmagenesis.com
About us
Oxford PharmaGenesis is an award-winning HealthScience Communications consultancy providing services to the healthcare industry, professional societies and patient groups through our specialist practices.
With offices in Melbourne, Oxford, London, Cardiff and Philadelphia, Oxford PharmaGenesis has a diverse client list comprising a number of healthcare organizations, including pharmaceutical, specialist devices, diagnostics and nutraceuticals companies, and professional societies, patient groups and academic institutions.
Category: BioMelbourne News
BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.
We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.
